InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

InMode (Nasdaq: INMD) will participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference in Snowbird, UT.

Rhea-AI Summary

InMode (Nasdaq: INMD) will participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference in Snowbird, UT. Yair Malca, Chief Financial Officer, will host investor meetings on Wednesday, February 11, 2026. Interested investors should contact their BTIG salesperson to schedule a meeting and may visit InMode's investor relations site for event details.

Argus Feb 3 session

-4.33% close to close Open Argus

Details

News Market Reaction – INMD

In the Feb 3 session, INMD declined 4.33%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights InMode’s continued engagement with the investment community via the BTI...

Analysis

This announcement highlights InMode’s continued engagement with the investment community via the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference on February 11, 2026. It follows recent financial updates and strategic discussions, including prior guidance and an offer proposal. Investors may focus on how messaging at this conference complements earlier disclosures and any future filings, especially given the company’s history of notable news around earnings and governance events.

Key Figures

Conference edition: 13th annual Conference date: February 11, 2026

Conference edition

13th annual

BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

Conference date

February 11, 2026

BTIG conference investor meetings in Snowbird, UT

Historical Context

5 past events · Latest: Jan 28

5 events

1. Jan 28

   Partial buyout offer

   24h Move

   -0.8%

   51% acquisition proposal at $18 per share premium to prior price.

2. Jan 08

   Guidance & call date

   24h Move

   -8.8%

   Preliminary Q4/FY2025 results and FY2026 revenue guidance announcement.

3. Nov 05

   Q3 earnings

   24h Move

   -0.7%

   Q3 2025 results with lower revenue year over year and reaffirmed guidance.

4. Nov 03

   Management change

   24h Move

   -0.5%

   Appointment of Michael Dennison as President of North America.

5. Oct 30

   Investor conferences

   24h Move

   -1.4%

   Planned participation in three November 2025 investor conferences.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will host investor meetings at the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference in Snowbird, UT on Wednesday, February 11, 2026.

Interested investors are welcome to contact their BTIG salesperson and schedule a meeting.

For more information about the event, visit InMode's investor relations site here.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:

Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com 

Photo - https://mma.prnewswire.com/media/1064477/5747577/InMode_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-to-participate-in-the-13th-annual-btig-medtech-digital-health-life-sciences--diagnostics-tools-conference-302676552.html

SOURCE InMode Ltd.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will InMode (INMD) hold investor meetings at the BTIG conference?

InMode will hold investor meetings on Wednesday, February 11, 2026 in Snowbird, UT with its CFO hosting. According to InMode, investors should contact their BTIG salesperson to schedule meetings and visit the company's investor relations site for event details.

Who from InMode (INMD) will represent the company at the BTIG MedTech conference?

Yair Malca, InMode's Chief Financial Officer, will represent the company and host investor meetings at the conference. According to InMode, interested investors may arrange one-on-one meetings through their BTIG salesperson and check the investor relations site for more information.

How can investors schedule a meeting with InMode (INMD) at the February 11, 2026 conference?

Investors should contact their BTIG salesperson to schedule meetings with InMode's CFO on February 11, 2026. According to InMode, the company asks investors to coordinate through BTIG and refers them to the investor relations site for additional event information.

Where is the 13th Annual BTIG MedTech conference that InMode (INMD) will attend?

The conference takes place in Snowbird, Utah, and InMode's meetings are scheduled for February 11, 2026. According to InMode, attendees and investors should use BTIG contacts to arrange meetings and consult the investor relations site for specifics.

Will InMode (INMD) provide a public webcast or presentation at the BTIG conference?

The announcement lists investor meetings but does not mention a public webcast or presentation at the conference. According to InMode, investors seeking more information should contact BTIG salespeople and consult the company's investor relations site for any updates.

What should shareholders expect from InMode's (INMD) participation in the BTIG MedTech conference?

Shareholders can expect investor meetings led by the CFO on February 11, 2026 in Snowbird, UT rather than a public corporate presentation. According to InMode, scheduling is managed through BTIG and event details are posted on the investor relations site.